Data / Drug companies / Clinique Laboratories LLC
Clinique Laboratories LLC: 50 products in the FDA NDC directory, labeler code 49527
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Clinique Laboratories LLC (labeler code 49527) lists 50 products in the FDA National Drug Code Directory, covering 19 finished drugs by generic name. By type: 40 over the counter drugs, 10 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 27, 2026.
The request: Watch Clinique Laboratories LLC (FDA labeler code 49527): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 49527
- Products in commercial distribution
- 50
- Packages
- 72
- Finished drugs by generic name
- 19
- Prescription products
- 0
- Over the counter products
- 40
- Flagged as original packager
- 40 of 40 products that carry the flag
- Started marketing in the last 12 months
- 4
- Products with a marketing end date set
- 1
- Earliest marketing start
- September 1, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 40 | 80% |
| Drugs for further processing | 10 | 20% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 40 | 80% |
| Drugs for further processing | 10 | 20% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 5 | 330 |
| Titanium dioxide and zinc oxide | 4 | 46 |
| Octinoxate, titanium dioxide, and zinc oxide | 4 | 4 |
| Octinoxate, octisalate, and titanium dioxide | 3 | 2 |
| Octinoxate, octisalate, titanium dioxide, and zinc oxide | 3 | 2 |
| Avobenzone and octisalate | 3 | 1 |
| Avobenzone,homosalate,octisalate,octocrylene | 2 | 12 |
| Avobenzone,homosalate,octinoxate,octisalate | 2 | 1 |
| Avobenzone,homosalate,octisalate, and octocrylene | 2 | 1 |
| Avobenzone, homosalate, and octisalate | 1 | 6 |
| Titanium dioxide, zinc oxide | 1 | 255 |
| Avobenzone, octinoxate, octisalate, and oxybenzone | 1 | 2 |
| Octinoxate and titanium dioxide | 1 | 10 |
| Zinc oxide and titanium dioxide | 1 | 12 |
| Homosalate, octisalate, and avobenzone | 1 | 2 |
| Octinoxate, titanium dioxide | 1 | 10 |
| Ensulizole, octinoxate, octisalate, and zinc oxide | 1 | 3 |
| Avobenzone, octisalate, and octocrylene | 1 | 11 |
| Aluminum chlorohydrate | 1 | 46 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 28 | 56% |
| Liquid | 10 | 20% |
| Lotion | 7 | 14% |
| Gel | 2 | 4% |
| Powder | 1 | 2% |
| Emulsion | 1 | 2% |
| Stick | 1 | 2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Uv solutions brightening tinted broad spectrum spf 50 sunscreen niacinamide antioxidants dark shade | 49527-228 | Cream | Over the counter monograph drugs | March 27, 2026 |
| Uv solutions hydrating broad spectrum spf 50 | 49527-224 | Cream | Over the counter monograph drugs | February 1, 2026 |
| Uv solutions mattifying broad spectrum spf 50 | 49527-226 | Cream | Over the counter monograph drugs | January 1, 2026 |
| Clinique for men daily hydrator broad spectrum spf 35 | 49527-223 | Cream | Over the counter monograph drugs | December 1, 2025 |
| Uv solutions brightening tinted broad spectrum spf 50 sunscreen niacinamide antioxidants | 49527-227 | Cream | Over the counter monograph drugs | September 1, 2025 |
| Avobenzone,homosalate,octisalate,octocrylene | 49527-910 | Cream | Drugs for further processing | May 21, 2025 |
| Dramatically different moisturizing ltn broad spectrum spf35 | 49527-222 | Cream | Over the counter monograph drugs | March 31, 2025 |
| Avobenzone,homosalate,octisalate,octocrylene | 49527-909 | Lotion | Drugs for further processing | January 10, 2025 |
| Salicylic acid | 49527-906 | Liquid | Drugs for further processing | December 20, 2024 |
| Avobenzone,homosalate,octinoxate,octisalate | 49527-905 | Cream | Drugs for further processing | December 20, 2024 |
| Avobenzone,homosalate,octinoxate,octisalate | 49527-904 | Cream | Drugs for further processing | December 20, 2024 |
| Titanium dioxide, zinc oxide | 49527-903 | Liquid | Drugs for further processing | December 20, 2024 |
| Octinoxate, octisalate, titanium dioxide, and zinc oxide | 49527-902 | Cream | Drugs for further processing | December 20, 2024 |
| Octinoxate, octisalate, titanium dioxide, and zinc oxide | 49527-901 | Cream | Drugs for further processing | December 20, 2024 |
| Octinoxate, titanium dioxide, and zinc oxide | 49527-900 | Liquid | Drugs for further processing | December 20, 2024 |
| Ensulizole,octinoxate,octisalate, and zinc oxide | 49527-907 | Liquid | Drugs for further processing | November 5, 2024 |
| Even better clinical vitamin makeup broad spectrum spf 45 | 49527-220 | Liquid | Over the counter monograph drugs | October 4, 2024 |
| Repairwear laser focus spf 15 line smoothing co/o | 49527-118 | Cream | Over the counter monograph drugs | February 9, 2024 |
| Cl eb matte makeup broad spectrum spf 15 | 49527-113 | Emulsion | Over the counter monograph drugs | October 20, 2023 |
| Even better clinical acne solutions | 49527-114 | Liquid | Over the counter monograph drugs | September 8, 2023 |
| Smart clinical repair broad spectrum spf 30 | 49527-083 | Cream | Over the counter monograph drugs | May 12, 2023 |
| Moisture surge spf | 49527-084 | Cream | Over the counter monograph drugs | November 7, 2022 |
| Moisture surge cc broad spectrum spf 30 hydrating colour corrector | 49527-029 | Cream | Over the counter monograph drugs | October 5, 2022 |
| Clinique for men broad spectrum spf 21 moisturizer | 49527-081 | Lotion | Over the counter monograph drugs | July 21, 2021 |
| Clinique even better clinical serum foundation broad spectrum spf 25 | 49527-080 | Liquid | Over the counter monograph drugs | September 24, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.